 |
| Global U.S. Urea Cycle Disorders Treatment Market Growth |
The urea cycle disorders (UCD) treatment market in the United States primarily
deals with drugs and procedures meant for managing urea cycle disorders. UCDs
are a group of rare genetic disorders that affect the body’s ability to remove
ammonia from the bloodstream. This can lead to a buildup of ammonia in the
blood, which can be dangerous for the brain.
The global
U.S. Urea Cycle Disorders Treatment Market is estimated to be valued at US$ 510 Mn in 2023 and is expected to
exhibit a CAGR of 6.0% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market Opportunity:
The market is expected to witness significant growth owing to the increasing
newborn screening programs across various states in the US. Most states
currently screen newborns for several treatable UCDs. This helps in early diagnosis
and treatment of the disorders, reducing the risks of long term health issues.
Additionally, increasing awareness among physicians and families regarding UCDs
is also supporting the growth of the market. Moreover, the availability of
specialty pharmacies that focus on providing medications and nutritional
supplements for managing rare diseases like UCDs has further boosted the
adoption of treatment options. Further research into developing newer drugs for
improved treatment outcomes will provide lucrative opportunities in the coming
years.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as high capital
investment required in R&D and clinical trials pose significant barriers.
However, prevalence of urea cycle disorders and demand for new treatments
provide opportunities.
Bargaining power of buyers: The bargaining power of buyers is high as they have
many treatment options and drug manufacturers to choose from. Rebates and
discounts offered by manufacturers also influences buyer choices.
Bargaining power of suppliers: Suppliers of raw materials and contract
manufacturing organizations have moderate bargaining power due to availability
of substitutes and dependence of manufacturers on stable supply chains.
Threat of new substitutes: Threat of new substitutes is high due to ongoing
research on novel therapeutic strategies like gene therapy and regenerative
medicine to treat urea cycle disorders.
Competitive rivalry: The market features strong competition among BB, Ascenz
Solutions Pte Ltd., and others to gain higher market share through new product
launches and strategic collaborations.
SWOT Analysis
Strengths: Growing prevalence, rising awareness, promising drug pipeline,
favorable government policies.
Weaknesses: High treatment costs, limited patient population, risk of relapse
post-transplantation, compliance challenges.
Opportunities: Untapped emerging markets, collaborations for R&D,
regulatory exclusivity of orphan drugs.
Threats: Patent expiries of blockbuster drugs, stringent regulations,
reimbursement hurdles.
Key Takeaways
Global
U.S. Urea Cycle Disorders Treatment Market Growth is expected to
witness high growth at a CAGR of 6% during the forecast period of 2023-2030
driven by increasing diagnosis rates and a robust product pipeline.
The North
American region currently dominates the market owing to presence of key
players, availability of advanced healthcare facilities and high healthcare
spending. This can be attributed to the increasing per capita healthcare
spending in countries like the US and Canada, presence of major players
operating in the region, and growing collaborations between market
participants.
Key players: Key players operating in the urea cycle disorders treatment market
include BB, Ascenz Solutions Pte Ltd., and others. BB leads the market with its
diversified product portfolio covering various stages of the disorder. Ascenz
Solutions is focused on developing novel therapeutic strategies like gene
therapy for long term management of urea cycle disorders.
Get More Insights On This Topic: https://www.newsanalyticspro.com/global-u-s-urea-cycle-disorders-treatment-market-size/